These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34058738)

  • 21. An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to Bardet-Biedl syndrome.
    Lazareva J; Brady SM; Yanovski JA
    Expert Opin Pharmacother; 2023 Apr; 24(6):667-674. PubMed ID: 37013719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Setmelanotide: A Novel Targeted Treatment for Monogenic Obesity.
    Pressley H; Cornelio CK; Adams EN
    J Pharm Technol; 2022 Dec; 38(6):368-373. PubMed ID: 36311304
    [No Abstract]   [Full Text] [Related]  

  • 23. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations.
    Branson R; Potoczna N; Kral JG; Lentes KU; Hoehe MR; Horber FF
    N Engl J Med; 2003 Mar; 348(12):1096-103. PubMed ID: 12646666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of bariatric surgery in patients with bi-allelic mutations in the POMC, LEPR, and MC4R genes.
    Poitou C; Puder L; Dubern B; Krabusch P; Genser L; Wiegand S; Verkindt H; Köhn A; von Schwartzenberg RJ; Flück C; Pattou F; Laville M; Kühnen P; Clément K
    Surg Obes Relat Dis; 2021 Aug; 17(8):1449-1456. PubMed ID: 34083135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use.
    Le Collen L; Delemer B; Poitou C; Vaxillaire M; Toussaint B; Dechaume A; Badreddine A; Boissel M; Derhourhi M; Clément K; Petit JM; Mau-Them FT; Bruel AL; Thauvin-Robinet C; Saveanu A; Cherifi BG; Le Beyec-Le Bihan J; Froguel P; Bonnefond A
    Genet Med; 2023 Jul; 25(7):100857. PubMed ID: 37092539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the Genetics of Early-Onset Obesity in a Cohort of Children From Qatar.
    Mohammed I; Haris B; Al-Barazenji T; Vasudeva D; Tomei S; Al Azwani I; Dauleh H; Shehzad S; Chirayath S; Mohamadsalih G; Petrovski G; Khalifa A; Love DR; Al-Shafai M; Hussain K
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3201-3213. PubMed ID: 37329217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of non-syndromic early-onset child and adolescent obese patients in terms of
    Nalbantoğlu Ö; Hazan F; Acar S; Gürsoy S; Özkan B
    J Pediatr Endocrinol Metab; 2022 Aug; 35(8):1041-1050. PubMed ID: 35801948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanocortins and the melanocortin 1 receptor, moving translationally towards melanoma prevention.
    Abdel-Malek ZA; Swope VB; Starner RJ; Koikov L; Cassidy P; Leachman S
    Arch Biochem Biophys; 2014 Dec; 563():4-12. PubMed ID: 25017567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency.
    Clément K; Biebermann H; Farooqi IS; Van der Ploeg L; Wolters B; Poitou C; Puder L; Fiedorek F; Gottesdiener K; Kleinau G; Heyder N; Scheerer P; Blume-Peytavi U; Jahnke I; Sharma S; Mokrosinski J; Wiegand S; Müller A; Weiß K; Mai K; Spranger J; Grüters A; Blankenstein O; Krude H; Kühnen P
    Nat Med; 2018 May; 24(5):551-555. PubMed ID: 29736023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment options for children with monogenic forms of obesity.
    Hainerová IA; Lebl J
    World Rev Nutr Diet; 2013; 106():105-12. PubMed ID: 23428688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of leptin and melanocortin-4 receptor gene mutations in children with severe obesity from Pakistani consanguineous families.
    Saeed S; Butt TA; Anwer M; Arslan M; Froguel P
    Mol Genet Metab; 2012 May; 106(1):121-6. PubMed ID: 22463805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monogenic human obesity syndromes.
    Farooqi IS
    Handb Clin Neurol; 2021; 181():301-310. PubMed ID: 34238466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.
    Haqq AM; Chung WK; Dollfus H; Haws RM; Martos-Moreno GÁ; Poitou C; Yanovski JA; Mittleman RS; Yuan G; Forsythe E; Clément K; Argente J
    Lancet Diabetes Endocrinol; 2022 Dec; 10(12):859-868. PubMed ID: 36356613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the leptin-melanocortin signalling pathway in the control of food intake.
    Beckers S; Zegers D; Van Gaal LF; Van Hul W
    Crit Rev Eukaryot Gene Expr; 2009; 19(4):267-87. PubMed ID: 19817705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel MC4R deletion coexisting with FTO and MC1R gene variants, causes severe early onset obesity.
    Neocleous V; Shammas C; Phelan MM; Fanis P; Pantelidou M; Skordis N; Mantzoros C; Phylactou LA; Toumba M
    Hormones (Athens); 2016 Jul; 15(3):445-452. PubMed ID: 27394708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The melanocortin pathway and energy homeostasis: From discovery to obesity therapy.
    Yeo GSH; Chao DHM; Siegert AM; Koerperich ZM; Ericson MD; Simonds SE; Larson CM; Luquet S; Clarke I; Sharma S; Clément K; Cowley MA; Haskell-Luevano C; Van Der Ploeg L; Adan RAH
    Mol Metab; 2021 Jun; 48():101206. PubMed ID: 33684608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies.
    Wabitsch M; Fehnel S; Mallya UG; Sluga-O'Callaghan M; Richardson D; Price M; Kühnen P
    Adv Ther; 2022 Apr; 39(4):1772-1783. PubMed ID: 35192151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10.
    Krude H; Biebermann H; Schnabel D; Tansek MZ; Theunissen P; Mullis PE; Grüters A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4633-40. PubMed ID: 14557433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide.
    Akinci B; Meral R; Rus D; Hench R; Neidert AH; DiPaola F; Westerhoff M; Taylor SI; Oral EA
    Endocrinol Diabetes Metab Case Rep; 2020 Mar; 2020():. PubMed ID: 32213649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of mutations in LEP, LEPR, and MC4R genes in individuals with severe obesity.
    Paolini B; Maltese PE; Del Ciondolo I; Tavian D; Missaglia S; Ciuoli C; Zuntini M; Cecchin S; Bertelli M; Pompucci G
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.